• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
* * * * * 1 votes

Official CX717 group buy thread.

cx717

  • Please log in to reply
3 replies to this topic

#1 Ark

  • Guest
  • 1,729 posts
  • 383
  • Location:Beijing China

Posted 17 November 2016 - 10:07 PM


This thread is to organize a CX717 group buy if possible. I've already contacted several labs and I'm awaiting their replies. For those who don't know CX717 is the latest and greatest Ampkine on the market, and is now phase II in trials.

https://en.m.wikiped...g/wiki/Ampakine

https://en.m.wikipedia.org/wiki/CX717

Cheers,

Ark.

Edited by Ark, 17 November 2016 - 10:09 PM.


#2 Ark

  • Topic Starter
  • Guest
  • 1,729 posts
  • 383
  • Location:Beijing China

Posted 17 November 2016 - 10:15 PM

NOOTROPIC SUPPLEMENT & SMART DRUG REVIEWS
HOME

POPULAR

RACETAMS

CHOLINE

NATURAL

DOPAMINERGICS
NOOTROPIC DRUGS

AMPAKINES

BRANDED PRODUCTS

RESEARCH CHEMICALS

RUSSIAN NOOTROPICS
Potential of Ampakine CX-717 as a Cognitive Enhancer

Rating:
CX-717 is the company code given to the ampakine developed by Cortex Pharmaceuticals. It is the most recent and perhaps the most promising of all the ampakines developed by the pharmaceutical company. The cx-717 is the fourth ampakine to come from Cortex after cx-516, cx-546, and cx-614. This ampakine has so far shown very strong potential as a cognitive enhancer. This new ampakine from Cortex has sparked interest among experienced nootropic users, and there have been unsubstantiated reports that some were able to synthesize it in their makeshift labs and have been selling versions of cx-717 online.

Cortex Pharmaceuticals has been trying to get approval for the Phase II testing of cx-717 from the USFDA. In 2005, the FDA gave Cortex permission to proceed with the testing of cx-717 as a means to manage and treat ADHD, some sleeping disorders, and Alzheimer’s disease. Testing was halted by the FDA in 2007. The FDA issued permit and halted the testing several more times until Cortex finally decided to stop with any more tests with cx-717 for neurological and psychological conditions.

CX 717The initial research on cx-717 was funded partially by the United States Defense Advanced Research Projects Agency (DARPA) to explore the ampakine’s potential for military applications such as relief from fatigue due to sleeplessness. It is for this same reason why conspiracy theories abound with regards to the FDA’s refusal to allow Cortex Pharmaceutical to proceed with Phase IIb of testing cx-717. The FDA’s official reason for disallowing the Phase IIb of cx-717 testing is that the agency believes that the ampakine is toxic.

Researchers Christopher Marrs and Gary Rogers are credited with the creation of cx-717 in 1996 in Cortex Pharmaceutical laboratories. Cortex is a well-known pharmaceutical entity that has been deeply involved in the development of ampakines for the treatment of various neurological and psychological conditions. The company has likewise in the past have collaborated with established multi-national pharmaceutical companies such as Shire and Servier.


Much like its predecessors, cx-717 showed a very strong potential in its early clinical trials with laboratory animals. Early clinical studies suggested that cx-717 can significantly improve memory and a host of other cognitive functions. Based on early tests, it would also seem as though cx-717 has solved the problems plaguing its predecessors such as poor oral bioavailability, short half-lives, and less than desirable potency. As the early tests have shown, cx-717 seems to have decent bioavailability (with 800mg doses), lasts in the system much longer, and are significantly more potent that any of the previously developed CX’s.

In addition to its cognitive enhancing properties, cx-717 has also shown the ability to reverse respiratory stress and depression, which are often caused by opioids analgesics and barbiturates. A study on this ability of cx-717 has been approved and is still in progress in Germany.

Despite the potential of cx-717 as a cognitive enhancer for the treatment of neurological and psychological conditions, the FDA issue seems to halt any progress in this direction for the moment. The study sponsored by the DARPA also seems to conclude that cx-717 does not have the ability to increase alertness and improve mental performance in sleep deprived individuals. Although some may contend that the findings flawed, the results of the studies stand.

PROS

It shows promise as a cognitive enhancer.
It shows promise as a treatment for a variety of neurological and psychological disorders.
It is an improvement from the three previous CX’s from Cortex.
It shows potential as a treatment and management for respiratory depression induced by opiate based painkillers.
CONS

It has limited human trials.
It may not actually work as indicated by one study.
The FDA may be right in saying that it is toxic and unsafe.
Its supply is limited.
While it trying out a unique and controversial cognitive enhancer such as the cx-717 may seem seductively appealing to some nootropic users, it may actually turn out to be a dud, much like the earlier CX-es. If you want an effective ampakine that is both potent and safe, look in the direction of sunifiram and unifiram.

RELATED REVIEWS

PEPA medicine
Nootropic Properties of PEPA
CX-516
Brain Stimulating Effect of Ampakine CX-516
CX-546
CX-546 Ampakine for Better Antipsychotic Reactions in the Brain

CX-614
CX-614 Ampakine, Effective and Potent Cognitive Enhancer
Laboratoires Servier
Neuroprotective Abilities of S-18986 Ampakine

Speak Your Mind



Name *

Email *

Website
POST COMMENT
CATEGORIES

Acetylcholinesterase Inhibitors
ADHD Alternatives
Amino Acids
Ampakines
Anxiolytic
Articles
Nootropic Comparisons
Branded Products
Choline Supplements
Eugeroics
Histamine Receptors
Natural Nootropics
Herbal
Neurotransmitter Supplements
Dopaminergics
Seretongenics
Nootropic Drugs
Nootropic Stacks
Nootropic Supplements
Popular
Racetams
Research Chemicals
Russian Nootropics
Stimulants
SEARCH


Search this website…
SEARCH
POPULAR

piracetam
Cognitive Benefits of Piracetam: Dosage, Side effects, Stacking

aniracetam
Aniracetam for Improved Cognitive Functions

noopept
Noopept: A Strong Cholinergic Nootropic for Acetylcholine Receptors

SUNIFIRAM
The Last Longer Nootropic Effects of Sunifiram

Adrafinil online
Noticeable Effects of Adrafinil

RECENT POSTS

How and Why To Stack Nootropics
Nootropics vs ADHD Psychostimulants
Nootropics Review: Dihexa
Review of Bifemelane
Picamilon – The Remarkable Nootropic Drug
PAGES

Contact
Blog
Privacy Policy
SOCIAL

Facebook Rss Twitter
Copyright © 2016 | nootropicsupplementreview.com This website is strictly meant for educational purposes and Is not meant to supplement the advice of a medical professional. The supplements reviewed have not been evaluated by the FDA and are not meant to cure, diagnose or prevent any disease. There may be affiliate links on this site

sponsored ad

  • Advert
Click HERE to rent this advertising spot for BRAIN HEALTH to support LongeCity (this will replace the google ad above).

#3 Ark

  • Topic Starter
  • Guest
  • 1,729 posts
  • 383
  • Location:Beijing China

Posted 18 November 2016 - 09:49 AM

Please note, if someone else with more experience running group buys wants to take over be my guest.

sponsored ad

  • Advert
Click HERE to rent this advertising spot for BRAIN HEALTH to support LongeCity (this will replace the google ad above).

#4 Ark

  • Topic Starter
  • Guest
  • 1,729 posts
  • 383
  • Location:Beijing China

Posted 24 November 2016 - 05:21 AM

The prices I've been quoted are much greater in cost then I would feel comfortable covering if something went wrong.

So I'm vacating organizing this group buy, perhaps someone else will find a better source that is affordable and this thread will live again someday.

Until then Sayōnara...

Edited by Ark, 24 November 2016 - 05:25 AM.






Also tagged with one or more of these keywords: cx717

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users